Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Cell-substrate adhesion drives Scar/WAVE activation and phosphorylation by a Ste20-family kinase, which controls pseudopod lifetime.

Tytuł:
Cell-substrate adhesion drives Scar/WAVE activation and phosphorylation by a Ste20-family kinase, which controls pseudopod lifetime.
Autorzy:
Singh SP; CRUK Beatson Institute, Glasgow, United Kingdom.
Thomason PA; CRUK Beatson Institute, Glasgow, United Kingdom.
Lilla S; CRUK Beatson Institute, Glasgow, United Kingdom.
Schaks M; Zoological Institute, Technische Universität Braunschweig, Braunschweig, Germany & Cell Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Tang Q; Brandeis University, Waltham, Massachusetts, United States of America.
Goode BL; Brandeis University, Waltham, Massachusetts, United States of America.
Machesky LM; CRUK Beatson Institute, Glasgow, United Kingdom.
Rottner K; Zoological Institute, Technische Universität Braunschweig, Braunschweig, Germany & Cell Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Insall RH; CRUK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Źródło:
PLoS biology [PLoS Biol] 2020 Aug 03; Vol. 18 (8), pp. e3000774. Date of Electronic Publication: 2020 Aug 03 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science, [2003]-
MeSH Terms:
Dictyostelium/*genetics
MAP Kinase Kinase Kinase 3/*genetics
Protozoan Proteins/*genetics
Pseudopodia/*metabolism
Wiskott-Aldrich Syndrome Protein Family/*genetics
Animals ; CRISPR-Cas Systems ; Cell Adhesion ; Cell Line, Tumor ; Chemotaxis/genetics ; Dictyostelium/metabolism ; Dictyostelium/ultrastructure ; Gene Editing/methods ; Gene Expression Regulation ; MAP Kinase Kinase Kinase 3/metabolism ; Melanocytes/metabolism ; Melanocytes/ultrastructure ; Mice ; Mitogen-Activated Protein Kinase 1/genetics ; Mitogen-Activated Protein Kinase 1/metabolism ; Mutation ; NIH 3T3 Cells ; Phenotype ; Phosphorylation ; Ploidies ; Protozoan Proteins/metabolism ; Pseudopodia/genetics ; Pseudopodia/ultrastructure ; Wiskott-Aldrich Syndrome Protein Family/metabolism
References:
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1098-103. (PMID: 15657136)
J Biol Chem. 2006 Oct 20;281(42):31290-7. (PMID: 16899465)
Anal Chem. 2002 Oct 15;74(20):5383-92. (PMID: 12403597)
Curr Biol. 1996 Jun 1;6(6):719-29. (PMID: 8793298)
Cell Motil Cytoskeleton. 2009 Jan;66(1):36-47. (PMID: 19012317)
Curr Biol. 2003 Oct 28;13(21):1867-75. (PMID: 14588242)
J Biochem. 2007 Mar;141(3):319-25. (PMID: 17202194)
Dev Cell. 2019 Feb 25;48(4):491-505.e9. (PMID: 30612939)
Nat Rev Mol Cell Biol. 2014 Sep;15(9):577-90. (PMID: 25145849)
J Cell Sci. 2012 Mar 1;125(Pt 5):1165-76. (PMID: 22349699)
Trends Cell Biol. 2015 Jul;25(7):388-97. (PMID: 25824971)
PLoS Biol. 2007 Sep;5(9):e221. (PMID: 17696648)
Elife. 2017 Sep 26;6:. (PMID: 28949297)
J Biol Chem. 2007 Dec 7;282(49):35666-78. (PMID: 17932039)
Gene. 2017 Mar 20;605:20-31. (PMID: 28007610)
Nat Commun. 2017 Mar 22;8:14832. (PMID: 28327544)
J Cell Biol. 1997 Jul 28;138(2):349-61. (PMID: 9230077)
J Immunol. 1998 Nov 15;161(10):5681-6. (PMID: 9820549)
Sci Signal. 2011 Oct 25;4(196):rs11. (PMID: 22028470)
Mol Cell. 2011 Mar 18;41(6):661-71. (PMID: 21419341)
Small GTPases. 2013 Apr-Jun;4(2):110-5. (PMID: 23503127)
Nature. 2002 Aug 15;418(6899):790-3. (PMID: 12181570)
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14449-54. (PMID: 21844371)
ACS Chem Biol. 2016 Dec 16;11(12):3300-3304. (PMID: 27792307)
J Biol Chem. 1991 Aug 15;266(23):15180-4. (PMID: 1907971)
Cell Motil Cytoskeleton. 2009 Nov;66(11):929-39. (PMID: 19479821)
Nat Cell Biol. 2018 Oct;20(10):1159-1171. (PMID: 30250061)
J Cell Biol. 2012 Aug 20;198(4):501-8. (PMID: 22891261)
J Cell Biol. 1995 Jun;129(6):1667-75. (PMID: 7790362)
Plasmid. 2009 Mar;61(2):110-8. (PMID: 19063918)
Nat Biotechnol. 2008 Dec;26(12):1367-72. (PMID: 19029910)
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7727-E7736. (PMID: 28847951)
Nat Cell Biol. 2007 Feb;9(2):193-200. (PMID: 17220879)
J Cell Biol. 2018 Feb 5;217(2):701-714. (PMID: 29191847)
FEBS Lett. 1987 Mar 23;213(2):316-8. (PMID: 3556584)
J Cell Sci. 1993 Dec;106 ( Pt 4):1005-13. (PMID: 7510298)
Biophys J. 1998 Jan;74(1):514-22. (PMID: 9449351)
Curr Biol. 2003 Sep 2;13(17):1480-7. (PMID: 12956949)
Curr Biol. 1998 Dec 17-31;8(25):1347-56. (PMID: 9889097)
Curr Biol. 2012 Apr 10;22(7):553-61. (PMID: 22386315)
Methods Mol Biol. 2013;983:59-92. (PMID: 23494302)
Biotechniques. 2013 Jul;55(1):39-41. (PMID: 23834384)
Curr Opin Cell Biol. 2014 Oct;30:60-7. (PMID: 24998184)
J Cell Sci. 1984 Jun;68:139-51. (PMID: 6092396)
Dev Cell. 2009 Sep;17(3):310-22. (PMID: 19758556)
J Cell Sci. 2007 Dec 1;120(Pt 23):4144-54. (PMID: 18032787)
Biophys J. 2004 Nov;87(5):3493-503. (PMID: 15347592)
Biotechniques. 2001 Nov;31(5):1140-2, 1144, 1146-9. (PMID: 11730020)
Cell. 2007 Feb 9;128(3):561-75. (PMID: 17289574)
Cell. 2019 Jun 27;178(1):12-25. (PMID: 31251912)
Curr Biol. 2019 Dec 16;29(24):4169-4182.e4. (PMID: 31786060)
Curr Biol. 2009 Feb 10;19(3):253-9. (PMID: 19200726)
J Cell Biol. 2012 Apr 16;197(2):239-51. (PMID: 22492726)
Curr Biol. 2018 Nov 19;28(22):3674-3684.e6. (PMID: 30393033)
Mol Cell. 2009 Nov 13;36(3):512-24. (PMID: 19917258)
Nat Cell Biol. 2016 Feb;18(2):191-201. (PMID: 26689677)
J Biol Chem. 1996 Feb 16;271(7):3351-4. (PMID: 8631932)
PLoS One. 2009 Aug 31;4(8):e6842. (PMID: 19718261)
PLoS Biol. 2006 Feb;4(2):e38. (PMID: 16417406)
Nature. 2009 Sep 3;461(7260):99-103. (PMID: 19693013)
J Biol Chem. 1999 Sep 24;274(39):27605-9. (PMID: 10488099)
J Cell Biol. 1998 Jun 29;141(7):1529-37. (PMID: 9647646)
Eukaryot Cell. 2008 May;7(5):906-16. (PMID: 18375618)
Nat Rev Mol Cell Biol. 2010 Jun;11(6):453-8. (PMID: 20445546)
Grant Information:
24452 United Kingdom CRUK_ Cancer Research UK; A17196 United Kingdom CRUK_ Cancer Research UK; A20017 United Kingdom CRUK_ Cancer Research UK; R01 GM063691 United States GM NIGMS NIH HHS; R35 GM134895 United States GM NIGMS NIH HHS; A20017 United Kingdom CRUK_ Cancer Research UK
Substance Nomenclature:
0 (Protozoan Proteins)
0 (SCAR protein, Dictyostelium)
0 (Wiskott-Aldrich Syndrome Protein Family)
EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1)
EC 2.7.11.25 (MAP Kinase Kinase Kinase 3)
Entry Date(s):
Date Created: 20200804 Date Completed: 20200917 Latest Revision: 20240210
Update Code:
20240210
PubMed Central ID:
PMC7425996
DOI:
10.1371/journal.pbio.3000774
PMID:
32745097
Czasopismo naukowe
The Scar/WAVE complex is the principal catalyst of pseudopod and lamellipod formation. Here we show that Scar/WAVE's proline-rich domain is polyphosphorylated after the complex is activated. Blocking Scar/WAVE activation stops phosphorylation in both Dictyostelium and mammalian cells, implying that phosphorylation modulates pseudopods after they have been formed, rather than controlling whether they are initiated. Unexpectedly, phosphorylation is not promoted by chemotactic signaling but is greatly stimulated by cell:substrate adhesion and diminished when cells deadhere. Phosphorylation-deficient or phosphomimetic Scar/WAVE mutants are both normally functional and rescue the phenotype of knockout cells, demonstrating that phosphorylation is dispensable for activation and actin regulation. However, pseudopods and patches of phosphorylation-deficient Scar/WAVE last substantially longer in mutants, altering the dynamics and size of pseudopods and lamellipods and thus changing migration speed. Scar/WAVE phosphorylation does not require ERK2 in Dictyostelium or mammalian cells. However, the MAPKKK homologue SepA contributes substantially-sepA mutants have less steady-state phosphorylation, which does not increase in response to adhesion. The mutants also behave similarly to cells expressing phosphorylation-deficient Scar, with longer-lived pseudopods and patches of Scar recruitment. We conclude that pseudopod engagement with substratum is more important than extracellular signals at regulating Scar/WAVE's activity and that phosphorylation acts as a pseudopod timer by promoting Scar/WAVE turnover.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies